Benefits
Cognitive Function (Mixed Evidence)
Older 1940s research showed pregnenolone improved cognitive performance in industrial workers. Modern trials less consistent. Marx 2009 trial in schizophrenia patients showed cognitive improvements with high-dose pregnenolone (500 mg/day). Mechanism: neurosteroid effects.
Bipolar Disorder Adjunct (Research)
Brown 2014 trial of pregnenolone (500 mg/day) in bipolar depression showed reduced depression and anxiety vs placebo. Generated continuing research interest. Specific clinical context, not general use.
Schizophrenia Cognitive Symptoms (Research)
Multiple trials showing high-dose pregnenolone may improve negative and cognitive symptoms in schizophrenia. Adjunct only.
Joint Pain / Arthritis (Older Research)
1940s-50s research showed pregnenolone reduced arthritis symptoms. Largely abandoned as cortisone-type anti-inflammatories developed. Limited modern research.
Theoretical Anti-Aging / Hormone Precursor Support
Used in some integrative anti-aging protocols based on age-related decline in pregnenolone and downstream hormones. INSUFFICIENT EVIDENCE for anti-aging claims; reasonable mechanism but clinical translation unclear.
Mechanism of action
Steroidogenic Pathway Precursor
Pregnenolone is the FIRST steroid hormone synthesized from cholesterol — by CYP11A1 (cholesterol side-chain cleavage enzyme). All other steroid hormones (progesterone, cortisol, aldosterone, DHEA, testosterone, estrogens) derive from pregnenolone. Supplementation increases substrate availability.
Direct Neurosteroid Activity
Pregnenolone (and pregnenolone sulfate) acts directly on GABA-A and NMDA receptors — neurosteroid effects independent of conversion to other hormones. May contribute to cognitive and mood effects.
Pregnenolone Sulfate (PS) Effects
Pregnenolone is sulfated in body to PS — a NEGATIVE allosteric modulator of GABA-A and POSITIVE modulator of NMDA receptors. PS has alerting/cognitive effects; pregnenolone itself has more variable effects.
Variable Downstream Hormone Production
Supplemental pregnenolone is converted to varying amounts of progesterone, cortisol, DHEA, testosterone, estrogens depending on individual enzymatic activity. Effects differ between individuals — explains variable clinical responses.
Clinical trials
RCT of pregnenolone (500 mg/day) vs placebo in 80 bipolar depression patients for 12 weeks.
80 bipolar depression patients.
Significant reduction in depression and anxiety scores vs placebo. Generated interest in pregnenolone for mood disorders. Adjunctive — not replacement for evidence-based bipolar treatment.
RCT of pregnenolone (up to 500 mg/day) vs placebo in 21 schizophrenia patients for 8 weeks.
21 schizophrenia patients.
Significant improvement in negative symptoms and cognitive function vs placebo. Adjunct to standard antipsychotic treatment. Subsequent trials have mixed results.
About this ingredient
PREGNENOLONE (3β-hydroxypregn-5-en-20-one) is a STEROID HORMONE PRECURSOR — the FIRST steroid hormone synthesized from cholesterol via CYP11A1 (cholesterol side-chain cleavage) enzyme in adrenal glands, gonads (testes/ovaries), and brain (where it acts as neurosteroid). Often called 'MOTHER OF ALL STEROID HORMONES' because it is the precursor to: PROGESTERONE → cortisol, aldosterone; DHEA → androstenedione → testosterone, estrogens. Endogenous levels decline with age; this decline (and decline in downstream hormones) is one rationale for supplementation.
CRITICAL POSITIONING: pregnenolone is a HORMONE PRECURSOR, not a 'simple supplement' — has hormonal effects requiring caution. Available as DIETARY SUPPLEMENT in US (loophole based on 'natural' status, though synthesized from soy or yam diosgenin); restricted/prescription in many other countries.
EVIDENCE-BASED USES: (1) Cognitive function (mixed evidence; older research more positive); (2) BIPOLAR DEPRESSION adjunct (Brown 2014; high-dose pregnenolone); (3) SCHIZOPHRENIA cognitive/negative symptoms adjunct (Marx 2009 and others); (4) Older arthritis applications (largely abandoned for steroid drugs); (5) Anti-aging / 'adrenal support' integrative use (insufficient rigorous evidence).
CRITICAL SAFETY CAUTIONS: (1) HORMONAL EFFECTS — pregnenolone supplementation increases multiple downstream hormones in unpredictable ratios depending on individual metabolic pathway activity; effects vary widely between individuals; some experience progesterone-dominant effects (calming, sleep), others testosterone/DHEA-dominant (acne, oily skin, mood changes), others cortisol effects (stress hormones); (2) HORMONE-SENSITIVE CANCERS — pregnenolone converts to estrogens, testosterone, DHEA — concerning for: ER+ breast cancer, ovarian, endometrial, prostate cancers; AVOID without oncologist consultation; (3) PREGNANCY/LACTATION — pregnenolone is precursor to progesterone (which supports pregnancy) but supplementation safety unknown; AVOID without obstetric guidance; (4) PSYCHIATRIC CONDITIONS — high-dose pregnenolone studied as schizophrenia/bipolar ADJUNCT; for general mood support, lower doses; consult psychiatrist if relevant psychiatric condition; (5) PCOS — theoretical concern; pregnenolone may convert to testosterone and worsen androgenic symptoms; (6) DOSE — START LOW (5-10 mg/day); some integrative protocols use 10-30 mg/day; research doses (500 mg) are FAR HIGHER and used in specific psychiatric contexts; titrate based on response and labs; (7) HORMONE TESTING — for those using pregnenolone, periodic monitoring of: pregnenolone, DHEA-S, testosterone, estradiol, progesterone, cortisol — may guide dosing; (8) DRUG INTERACTIONS — multiple via hormonal pathways; consult prescriber if on hormone-related medications; (9) ELDERLY — theoretical 'replacement' rationale due to age-related decline; modest evidence for benefit; comprehensive approach to age-related cognitive/mood concerns is foundational; (10) AGE-RELATED COGNITIVE DECLINE — pregnenolone is one of several agents (DHEA, hormones, lifestyle, nutrition) considered in integrative protocols; not standalone; (11) US REGULATORY STATUS — sold as supplement in US but is genuinely a hormone; this is unusual and warrants caution about expecting only 'supplement-level' effects; (12) STARTING — those considering pregnenolone should: (a) work with knowledgeable practitioner, (b) get baseline hormone panel, (c) start very low, (d) monitor response and labs, (e) avoid in cancer history without oncology input.